GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Mankind Pharma Ltd
Mankind Pharma Pays Rs. 1250 Crore NCD Maturity, Rs. 50.07 Cr Interest
FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 16 Oct 2026, 05:04 PM IST  ·  BSE ID: b5e2abd1-1bff-4c64-8cd2-18d85ba41f58
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has fully repaid a debt of Rs. 1250 crore and paid interest on its borrowings on time.
🤖 AI Summary
  • Mankind Pharma completed NCD redemption of Rs. 12,50,00,00,000 on maturity.
  • Interest payment of Rs. 50,07,43,150 gross made on ISIN INE634S07025.
  • Second NCD series ISIN INE634S07033 interest payment of Rs. 99,89,79,452 gross processed.
  • All NCD obligations met on the stipulated payment dates.
  • Outstanding NCD balance is now zero post-redemption.
🔢 Key Numbers — exact figures from BSE filing, not rounded
NCD Redemption Amount (ISIN INE634S07025)
12,50,00,00,000
Gross Interest Paid (ISIN INE634S07025)
500,743,150
Net Interest Paid (ISIN INE634S07025)
499,741,677
Gross Interest Paid (ISIN INE634S07033)
998,979,452
Net Interest Paid (ISIN INE634S07033)
998,579,873
Outstanding Amount (₹) after redemption
0
🏢 How This Affects the Company
💰
Financial Impact
The repayment of Non-Convertible Debentures reduces the company's outstanding debt by Rs. 12,50,00,00,000. This improves the company's leverage ratios and frees up cash flow previously allocated to debt servicing.
⚠️
Risk Impact
Completion of NCD redemption eliminates the risk associated with these specific debt instruments, including potential default or refinancing concerns.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders as this concerns debt repayment by the company.
👤
Who Is Affected
Debenture holders of ISIN INE634S07025 and INE634S07033 are directly affected by the interest and redemption payments.
🔍
Management Signal
The timely payment signals management's commitment to fulfilling financial obligations and maintaining healthy credit standing.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next quarterly results disclosure for overall financial health.
Any future debt issuance or repayment plans.
Company's cash flow statement for debt servicing capacity.
LOW RISK Routine debt redemption and interest payment, indicating financial stability.
💡 Investor Takeaway
Mankind Pharma successfully redeemed Rs. 12,50,00,00,000 of Non-Convertible Debentures on maturity and paid interest for two series, with zero outstanding balance for the redeemed NCDs.
⚖️ Strengths & Concerns

✅ Positives

  • Full redemption of Rs. 12,50,00,00,000 NCDs on maturity date of October 16, 2026.
  • Timely payment of interest amounts, both gross and net of taxes, for two NCD series.
📅 Company Track Record
Previously, Mankind Pharma redeemed Rs. 12,50,00,00,000 NCDs on April 16, 2026, with zero outstanding balance at that time.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was the redemption amount for Mankind Pharma's NCDs on October 16, 2026?
Mankind Pharma redeemed Non-Convertible Debentures (NCDs) with an issue size of Rs. 12,50,00,00,000 on their maturity date.
How much interest did Mankind Pharma pay on its NCDs?
The company paid a gross interest of Rs. 500,743,150 on ISIN INE634S07025 and Rs. 998,979,452 on ISIN INE634S07033.
What is the outstanding balance of the redeemed NCDs?
The outstanding amount for the redeemed NCDs (ISIN INE634S07025) is Rs. 0 after the payment.
When was the last interest payment made before this date?
The last interest payment for both NCD series was on April 01, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.